Skip to main content
An official website of the United States government
Email

Gastrointestinal SPOREs

SPOREs in Gastrointestinal (GI) cancers focus on translational research in the gastrointestinal system and include cancers of the colon, rectum, stomach, esophagus, small intestine, liver, gallbladder and other digestive organs. Over 362,200 newly diagnosed cases of cancer in the digestive system and 174,520 deaths are expected in the United States in the year 2025, the American Cancer Society estimates. Colorectal and colon cancers are particularly prevalent and represented 8.7% of all new cancer cases in the U.S. in 2024, while being responsible for 53,010 deaths. Currently, GI SPOREs focus on cancers of the colon, rectum, esophagus, stomach, liver, and pancreas, which account for the majority of new diagnoses.

MDACC Gastrointestinal Cancer SPORE

Vanderbilt-Ingram Cancer Center Gastrointestinal Cancer SPORE

DFHCC Gastrointestinal Cancer SPORE

FHCRC Gastrointestinal Cancer SPORE

  • Reviewed:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Gastrointestinal SPOREs was originally published by the National Cancer Institute.”

Email